Stay updated on Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The clinical trial record for the dupilumab study in Chinese adults with moderate-to-severe atopic dermatitis is displayed, with study details, participant criteria, outcome measures, and related documents. The previous access-error content and NIH transition notice are no longer shown.
    Difference
    74%
    Check dated 2026-11-07T12:18:08.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T12:58:16.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T12:36:07.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.1 to v3.7.2; the page content remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T13:31:04.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-10T13:34:44.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden error, displaying a basic error page with a Home button instead of the study details and navigation.
    Difference
    19%
    Check dated 2026-09-19T18:36:10.000Z thumbnail image

Stay in the know with updates to Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page.